Biosceptre Secures Key U.S. Patent for Non-Functional P2X7 CAR-T Technology
Biosceptre is pleased to announce the grant of a pivotal [...]
Biosceptre meet with NSW Health Minister, Ryan Park
It was a privilege for Biosceptre CEO, Gavin Currie and [...]
Biosceptre secures £7m. to boost novel CAR T therapy
Biosceptre today announced the securing of £7m. (US$9.6m.) in funds [...]
Biosceptre boosts Australian biotech capacity with support for new lab
Biosceptre has today announced a partnership with the University of [...]
Biosceptre Signs Deal With Carina Biotech
Biosceptre is pleased to announce that an agreement has been [...]
Biosceptre attending J.P. Morgan Healthcare Conference in January 2020
Biosceptre will be attending the J.P. Morgan Healthcare Conference, January [...]
Biosceptre Board Changes as result of Sir Gregory Winter’s Nobel Prize
On behalf of Biosceptre we would like to congratulate Sir [...]
Biosceptre wins Gold Medal at China’s largest event for promoting innovation and entrepreneurship
Upon invitation from our lead investor Tuspark S&T, Biosceptre recently [...]
Update on Biosceptre’s Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v
Biosceptres' Phase I clinical trial for peptide vaccine BIL06v has [...]
Congratulations to Sir Greg Winter on award of Nobel Prize for Chemistry 2018
Biosceptre congratulates the chair of our Science Advisory Board and [...]